Enovis Corporation (ENOV) News
Track canonical SquawkNews coverage tagged to ENOV, Enovis Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 19 indexed stories across 9 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Nyxoah Appoints Liam Kelly as Chief Executive Officer
REGULATED INFORMATIONINSIDE INFORMATIONNyxoah Appoints Liam Kelly as Chief Executive OfficerFurther strengthening the Company’s strategic U.S. presence and focusMont-Saint-Guibert, Belgium — September 28, 2026, 10:30 pm
NEWS | Sep 28, 2026, 08:32 PM UTC
L
ENOV - Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
ENOV - Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
NEWS | Sep 22, 2026, 04:02 PM UTC
M
ENOV Amplitude acquisition targets 50% FCF conversion next year
ENOV says the Amplitude acquisition strengthens its robotics capabilities and supports a planned 2028 U.S. knee launch. It targets 50% free cash flow conversion next year and 70-80% by 2029, supported by stable ortho con
MNA | Sep 08, 2026, 06:28 PM UTC
L
Wells Fargo cuts Enovis price target to $33 from $39
Wells Fargo lowered its Enovis price target to $33.00 per share from $39.00, according to Benzinga ratings actions reported by TradingView News.
EQUITY | Sep 02, 2026, 02:48 PM UTC
L
Enovis price target cut to $47 from $55 by Citizens
Citizens cut its Enovis price target to $47.00 per share from $55.00, per Benzinga ratings actions via TradingView News.
EQUITY | Sep 02, 2026, 01:00 PM UTC
L
Enovis maintained at Buy; Freedom Capital Markets cuts target
Freedom Capital Markets reiterated Enovis as Buy and cut its price target to $36.00 from $41.00, per Benzinga/TradingView News.
EQUITY | Sep 02, 2026, 12:14 PM UTC
M
BTIG cuts Enovis price target to $36 from $40
BTIG cut its Enovis price target to $36.00 per share from $40.00, per Benzinga ratings actions.
EQUITY | Sep 02, 2026, 09:49 AM UTC
M
ENOV to acquire eCential Robotics for €155M plus milestones
ENOV will acquire eCential Robotics to accelerate entry into surgical robotics, focused on knee and shoulder applications using a unified technology platform. Deal value is €155M plus milestones, expected to drive growth
MNA | Sep 01, 2026, 06:05 PM UTC
M
ENOV to pay €155M upfront for eCential Robotics, with up to €35M milestones
ENOV said it will acquire eCential Robotics to accelerate its orthopedic enabling technology strategy, with a €155M upfront payment and up to €35M in milestones.
MNA | Sep 01, 2026, 01:46 PM UTC
L
ENOV to acquire eCential Robotics in €155M deal
ENOV will acquire eCential Robotics in a €155M deal plus milestones, targeting a 2026 close and expecting commercial traction in 2028, alongside long-term margin and cash flow improvements.
EARNINGS | Sep 01, 2026, 01:27 PM UTC
M
Enovis to enter definitive purchase agreement; close in 4Q
Enovis and ECentral expect to enter into a definitive purchase agreement, with an expected close in 4Q.
EQUITY | Sep 01, 2026, 10:47 AM UTC
L
ENOV - eCential Robotics Announces Binding Offer from Enovis
ENOV - eCential Robotics Announces Binding Offer from Enovis
EQUITY | Sep 01, 2026, 10:46 AM UTC
M
eCential Robotics announces binding offer from Enovis
eCential Robotics said Enovis entered a binding offer under which eCential Robotics’ platform would join Enovis’ enabling technology portfolio.
EQUITY | Sep 01, 2026, 10:45 AM UTC
M
Enovis makes binding offer to acquire eCential Robotics
Enovis (ENOV) says it has made a binding offer to acquire eCential Robotics.
MNA | Sep 01, 2026, 10:39 AM UTC
L
ENOV - Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
ENOV - Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
EQUITY | Aug 31, 2026, 08:15 PM UTC
L
Enovis Affirms FY2026 Adj EPS Guidance of $3.52-$3.73 vs $3.65 Est; Affirms FY2026 Sales Guidance of $2.310B-$2.370B vs $2.345B Est
Enovis (NYSE: ENOV ) affirms FY2026 Adj EPS guidance from $3.52-$3.73 to $3.52-$3.73 vs $3.65 analyst estimate. Affirms FY2026 sales outlook from $2.310 billion-$2.370 billion to $2.310 billion-$2.370 billion vs $2.345 b
EARNINGS | Aug 06, 2026, 10:05 AM UTC
L
ENOV - Enovis Announces Second Quarter 2026 Results
ENOV - Enovis Announces Second Quarter 2026 Results
EARNINGS | Aug 06, 2026, 10:05 AM UTC
L
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
EQUITY | Jul 28, 2026, 11:47 AM UTC
L
4 Top Growth Stocks Worth Buying Under $100 Today
2026-07-03 08:50:00 ET Not every great investment story comes from a household name. Sometimes the best opportunities are found in overlooked industrial and
EQUITY | Jul 03, 2026, 12:54 PM UTC